About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
PeerView Oncology
Basic Science
Genitourinary
Breast
Lung
Hematologic Oncology
Gastrointestinal
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
2020 HCC Update: Who Should Be Evaluated for Potential Curative Therapies? What Role Does LRT Play in Intermediate-Stage Disease?
By
PeerView Oncology
FEATURING
Matthew Johnson
,
Amit Singal
,
Richard S. Finn
By
PeerView Oncology
FEATURING
Matthew Johnson
,
Amit Singal
,
Richard S. Finn
175 views
December 4, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Gastrointestinal
17:30
PeerView Oncology
2020 HCC Update: Who Should Be Evaluated for Potential Curative Ther…
Feat.
M. Johnson,
A. Singal,
R. Finn
14:56
PeerView Oncology
2020 Updates on Advanced Gastric/GEJ Cancers: Efficacy Analysis of T…
Feat.
M. Shah,
B. Swed,
H. Heyison
